Tipifarnib | List of Frontiers open access articles

Original Research

Published on 29 May 2019

Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni

in Parasite and Host

Alexandra Probst
Thi N. Nguyen
Nelly El-Sakkary
Danielle Skinner
Brian M. Suzuki
Frederick S. Buckner
Michael H. Gelb
Conor R. Caffrey
Anjan Debnath

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2019.00180

6,588 views
14 citations

Original Research

Published on 20 Jun 2023

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma

in Head and Neck Cancer

Damian T. Rieke
Sebastian Schröder
Philippe Schafhausen
Eric Blanc
Erika Zuljan
Benjamin von der Emde
Dieter Beule
Ulrich Keller
Ulrich Keilholz
Konrad Klinghammer

Frontiers in Oncology

doi 10.3389/fonc.2023.1107134

5,226 views
8 citations

Original Research

Published on 03 Oct 2023

Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma

in Molecular Diagnostics and Therapeutics

Baozhu Zhang
Boyang Chang
Lu Wang
Yuzhong Xu

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1266515

4,719 views
4 citations

Original Research

Published on 30 Nov 2021

Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase

in Antimicrobials, Resistance and Chemotherapy

Lea Weber
Anna Hagemann
Jila Kaltenhäuser
Manuela Besser
Patrick Rockenfeller
Anja Ehrhardt
Ewa Stuermer
Hagen Sjard Bachmann

Frontiers in Microbiology

doi 10.3389/fmicb.2021.628283

4,828 views
9 citations

Original Research

Published on 20 Sep 2022

Exosomes form tunneling nanotubes (TUNTs) in the blood-brain barrier: a nano-anatomical perspective of barrier genesis

in Molecular Signalling and Pathways

Shireen Mentor
David Fisher

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2022.938315

6,043 views
15 citations

Original Research

Published on 09 Nov 2023

Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells

in Immunosuppression

Shilei Xu
Sebastian Dolff
Nils Mülling
Hagen S. Bachmann
Yang Dai
Monika Lindemann
Ming Sun
Oliver Witzke
Andreas Kribben
Benjamin Wilde

Frontiers in Transplantation

doi 10.3389/frtra.2023.1233322

2,220 views
1 citation

Articles

Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma

Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma

Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase

Exosomes form tunneling nanotubes (TUNTs) in the blood-brain barrier: a nano-anatomical perspective of barrier genesis

Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells